Should the International Trade Commission investigate complaints about allegedly falsely labeled drugs imported into the United States, or does the Food and Drug Administration have exclusive jurisdiction?

The U.S. Court of Appeals for the Federal Circuit wrestled with that issue Friday, and it didn’t get much help from government lawyers representing the two agencies, who were unable to unite behind a single theory.